← All diseases Cancer

Lung cancer (non-small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level evidence only (185)Meta-analysis (67)Treatment guideline (1)Randomized trial (51)Systematic review (38)Phase 3 study (28)Clinical trial (665)Review article (246)Early study (phase 1 or 2) (63)Case report (126)Laboratory or animal research (69)Commentary or Editorial (86)Retracted publication (14) Studies currently recruiting participants only (62)

Filter

Publications and studies (3220)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (2026-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer (2026-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC (2026-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial (2026-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer (2026-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study. (2026-06-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) (2026-06-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Electro-Acupuncture in Lung cancER : EALER Study (2026-06-24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Efficacy of tepotinib in patients with high-grade glioma with MET alterations: A case series. (2025/12/31) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Alhagi maurorum Extract Regulates the PI3K/AKT Cascade and Inhibits the Proliferation of the Lung Cancer Cell Line. (2025/12/30) ♡
• Molecular switch-mediated detection of EGFR deletion mutations and its application to cfDNA analysis. (2025/12/29) ♡
• Investigating monoclonal antibody against cytokeratin 19 tumor marker. (2025/12/28) ♡
• Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer. (2025/12/28) ♡
• Prognostic relevance of geriatric nutritional risk index and the prognostic nutritional index in geriatric extensive stage small cell lung cancer. (2025/12/27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A decade of Non-Small Cell Lung Cancer management: threats and opportunities in resource-limited setting. (2025/12/27) ♡
• Impact of pathologically confirmed inner lung tumors on nodal upstaging and feasibility of segmentectomy versus lobectomy. (2025/12/27) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer: Evidence to date and remaining questions. (2025/12/27) ♡
• A Retrospective Study of First-Line Immunotherapy for Advanced Non-Small Cell Lung Cancer in the Elderly. (2025/12/26) ♡
• Inflammation-Related Parameters in Lung Cancer Patients Followed in the Intensive Care Unit. (2025/12/23) ♡
• Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE Study. (2025/12/23) ♡
• The mechanism of prostaglandin E2 upregulation of programmed death ligand 1 expression promoting immune escape in non-small cell lung cancer. (2025/12/22) ♡
• First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials. (2025/12/22) ♡
• [Clinical Characteristics and Prognosis Analysis of Thoracic SMARCA4-deficient Undifferentiated Tumor versus SMARCA4-deficient Non-small Cell Lung Cancer]. (2025/12/20) ♡
• [Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis]. (2025/12/20) ♡
• [Identification of SORD as A Key Gene Mediating Osimertinib Primary Resistance in EGFR-Mutant Lung Adenocarcinoma via Machine Learning and Methylomics]. (2025/12/20) ♡
• Exploring the mechanism of Inula japonica Thunb. against non-small cell lung cancer using a computer-aided drug design approach. (2025/12/19) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical significance of Zongertinib in HER2-mutated non-small cell lung cancer: advancing targeted therapy options. (2025/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Osimertinib with chemotherapy in advanced non-small cell lung cancer with vaginal metastasis harboring EGFR exon 21 L858R and NTRK1 exon 16 V679M mutations: a case report with prolonged progression-free survival. (2025/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Seronegative Paraneoplastic Limbic Encephalitis in Non-Small Cell Lung Cancer: A Case of Neuropsychiatric Symptoms Resolving After Resection. (2025/12/19) ♡
• Association between advanced lung cancer inflammation index and postoperative mortality in lung cancer patients: a retrospective cohort study. (2025/12/17) ♡
• Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance. (2025/12/17) ♡
• Lobectomy offers higher incidence of up-staging in patients with T1a-c non-small cell lung carcinomas: Is completion lobectomy necessary? (2025/12/17) ♡
• Myocardial injury after lung cancer surgery as a predictor of postoperative long-term mortality: A prospective cohort study. (2025/12/17) ♡
• Prediction of immunotherapy efficacy for pulmonary lymphoepithelioma-like carcinoma using baseline routine blood tests and serum tumor markers: a multicenter retrospective study. (2025/12/16) ♡
• Risk stratification using a nomogram model for postoperative cancer-related fatigue in elderly survivors following early-stage non-small cell lung cancer resection. (2025/12/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies. (2025/12/11) ♡
• Rongbei Maimendong Decoction Promotes Radiosensitivity of Non-Small Cell Lung Cancer Cells by Inhibiting SOD1 Expression. (2025/12/08) ♡
• When wedge resection is good enough: Survival outcomes and nodal involvement of ground-glass-dominant stage IA non-small cell lung cancer. (2025/12/06) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Taletrectinib as an emerging therapy for ROS1-positive non-small cell lung cancer: findings from TRUST phase 2 trials. (2025/12/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New opportunities and challenges for nonshedder tumors. (2025/12/05) ♡
• Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases. (2025/12/05) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Engineered food-borne probiotics delivering checkpoint-inhibitor modulators. (2025/12/03) ♡
• National race-based disparities in referral to Commission on Cancer centers for lung cancer resection. (2025/12/03) ♡
• Quality of life and aspects related nutrition in advance stages non-small cell lung cancer patients. (2025/12/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Economics, efficacy and safety of five traditional Chinese medicine injections plus chemotherapy as adjuvant therapy for non-small cell lung cancer: A network meta-analysis. (2025/12/01) ♡
• From autoimmune inflammation to malignancy: causal genetic evidence for the RA-squamous cell lung cancer axis. (2025/12/01) ♡
• Beyond the third lumbar vertebra (L3): Thoracic computed tomography-derived muscle mass and quality assessment as a practical alternative for body composition analysis. (2025/12/01) ♡
• The dynamic nature of frailty in metastatic spine disease patients. (2025/12/01) ♡
• Retraction Note: Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β-catenin-c-myc-p53 pathway. (2025/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic utility of cachexia in lung cancer: A multicenter cohort analysis. (2025/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.